Benefits of Drug-Eluting Stents in Coronary Heart Disease Treatment with Emphasis on the Diabetic Subgroup
To access this article, please choose from the options below
PII: S1443-9506(06)00223-X
doi:10.1016/j.hlc.2006.09.005
© 2006 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved.
